Study guide

4.3 Neurological Emergencies & Acute Toxicology

Clinical Officers Council Pre-Internship Examination Kenya

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Overview & Exam Strategy

1.1 About the COC Pre-Internship Examination 1.2 Clinical Decision-Making & Preparation Strategy

2 Chapter 2: Infectious & Communicable Diseases (Internal Medicine)

2.1 Malaria Diagnosis & Case Management 2.2 Tuberculosis & Leprosy Control 2.3 HIV/AIDS & Opportunistic Infections 2.4 Enteric & Neglected Tropical Infections

3 Chapter 3: Cardiovascular & Respiratory Medicine (Internal Medicine)

3.1 Hypertension & Cardiovascular Disorders 3.2 Respiratory Disorders & Acute Emergencies 3.3 Venous Thromboembolism & Vascular Emergencies

4 Chapter 4: Metabolic, Gastrointestinal & Neurological Medicine (Internal Medicine)

4.1 Diabetes Mellitus & Endocrine Emergencies 4.2 Gastrointestinal & Hepatorenal Disorders 4.3 Neurological Emergencies & Acute Toxicology

5 Chapter 5: Trauma Resuscitation & Emergency Surgery (General Surgery)

5.1 ATLS Primary Survey & Trauma Resuscitation 5.2 Burn Assessment & Fluid Resuscitation 5.3 Surgical Wounds, Infections & Tetanus Prophylaxis

6 Chapter 6: Acute Abdomen & Gastrointestinal Surgery (General Surgery)

6.1 Acute Appendicitis & Peritonitis 6.2 Intestinal Obstruction & Abdominal Hernias 6.3 Hepatobiliary, Pancreatic & Anorectal Surgical Conditions

7 Chapter 7: Orthopedics, Urology & Special Surgical Emergencies (General Surgery)

7.1 Fractures, Dislocations & Cast Management 7.2 Acute Compartment Syndrome & Limb Emergencies 7.3 Urological Emergencies & Pelvic Trauma 7.4 Emergency Airway, Anesthesia & Oncology Screening

8 Chapter 8: Essential Newborn Care & Neonatal Conditions (Pediatrics)

8.1 Immediate Newborn Care & Neonatal Resuscitation 8.2 Neonatal Jaundice, Sepsis & Common Disorders 8.3 Low Birth Weight & Kangaroo Mother Care

9 Chapter 9: IMCI Guidelines & Common Pediatric Conditions (Pediatrics)

9.1 IMCI Principles & General Danger Signs 9.2 Cough, Fast Breathing & Pediatric Pneumonia 9.3 Pediatric Diarrheal Diseases & Dehydration 9.4 Acute Pediatric Infections: Meningitis, Croup & Febrile Seizures

10 Chapter 10: Child Nutrition, KEPI & Preventive Pediatrics (Pediatrics)

10.1 Severe Acute Malnutrition (SAM) Management 10.2 KEPI Immunization Schedule & Vaccine Logistics 10.3 Pediatric Prophylaxis & Early Infant Diagnosis

11 Chapter 11: Antenatal Care & Medical Complications of Pregnancy (Obstetrics & Gynecology)

11.1 Focused Antenatal Care & Routine ANC Screening 11.2 Hypertensive Disorders of Pregnancy & Eclampsia 11.3 Medical Disorders & Infections in Pregnancy

12 Chapter 12: Labor, Delivery & Obstetric Emergencies (Obstetrics & Gynecology)

12.1 Normal Labor & Partograph Monitoring 12.2 Active Management of the Third Stage of Labor & PPH 12.3 Antepartum Hemorrhage & Uterine Rupture 12.4 Induction of Labor & Malpresentation Emergencies

13 Chapter 13: Puerperium, Gynecological Disorders & Family Planning (Obstetrics & Gynecology)

13.1 Puerperal Sepsis & Postnatal Complications 13.2 Pelvic Inflammatory Disease & Gynecological Conditions 13.3 Modern Contraceptive Technology & WHO MEC Criteria

14 Chapter 14: Primary Health Care & Devolved Health Systems (Community Health)

14.1 Primary Health Care Principles & Universal Health Coverage 14.2 Kenya Health Service Delivery Structure & Devolved Governance 14.3 Kenya Community Health Strategy & Level 1 Services

15 Chapter 15: Epidemiology, Disease Surveillance & Outbreak Response (Community Health)

15.1 Epidemiological Principles & Health Indicators 15.2 Integrated Disease Surveillance and Response (IDSR) 15.3 Vector Control & Neglected Tropical Diseases

16 Chapter 16: Environmental Health, Waste Management & Cold Chain (Community Health)

16.1 Water Quality & Household Water Treatment 16.2 Community Sanitation & Excreta Disposal 16.3 Healthcare Waste Management & Infection Prevention Control 16.4 Vaccine Cold Chain Management & Quality Monitoring

17 Chapter 17: Health Systems Management — Leadership, Policy & Financing

17.1 Management Functions, Leadership & Supportive Supervision 17.2 Kenya Health Policy, Planning & the Devolved Budget Cycle 17.3 Health Financing & Universal Health Coverage under the Social Health Authority 17.4 Human Resource Management, Scheme of Service & Performance Appraisal

18 Chapter 18: Health Commodities, Information & Quality Management

18.1 Health Commodity & Supply Chain Management (KEMSA) 18.2 Health Information Systems, Records & KHIS Reporting 18.3 Quality Improvement, Clinical Audit & Patient Safety

19 Chapter 19: Professional Practice, Ethics & Medico-Legal Responsibility

19.1 Scope of Practice, Registration, Licensing & Professional Discipline 19.2 Medical Ethics, Informed Consent & Patient Rights 19.3 Medico-Legal Documentation, Statutory Notification & Facility Safety Governance

4.3 Neurological Emergencies & Acute Toxicology

Key Takeaways Explain This Topic AI

Acute Bacterial Meningitis presents with the classic triad of fever, neck stiffness, and altered mental state; diagnostic lumbar puncture demonstrates cloudy/turbid CSF, elevated opening pressure (> 200 mmH2O), marked neutrophilic pleocytosis (> 1000 cells/mm3), protein > 1.0 g/L, and CSF-to-blood glucose ratio < 0.40; IV Dexamethasone 10 mg must be administered immediately prior to or with the first dose of IV Ceftriaxone 2 g 12-hourly.

Acute stroke management requires rapid FAST assessment, emergency non-contrast brain CT to differentiate ischemic (85%) from hemorrhagic stroke (15%), permissive hypertension in ischemic stroke (withholding antihypertensives unless BP > 220/120 mmHg), and early antiplatelet therapy (Aspirin 300 mg daily within 24–48 hours after hemorrhage is excluded).

Status Epilepticus is defined as continuous seizure activity lasting >= 5 minutes or >= 2 discrete seizures without full recovery of consciousness between episodes; emergency pharmacotherapy follows a timed algorithm: IV Diazepam 10 mg (0–10 min), followed by IV Phenytoin loading dose 18–20 mg/kg at <= 50 mg/min (10–30 min), escalating to endotracheal intubation and continuous general anesthesia infusion (Propofol or Midazolam) for refractory status (> 30 min).

Organophosphate and carbamate poisoning precipitates an acute cholinergic toxidrome (SLUDGE / DUMBELS); life-saving therapy demands personal protective equipment, total removal of clothing, dermal washing with soap and water, and titrated intravenous Atropine until full reversal of pulmonary secretions and bronchospasm is achieved, supplemented with Pralidoxime (2-PAM).

Paracetamol overdose (> 150 mg/kg) causes centrilobular hepatic necrosis via toxic NAPQI metabolite accumulation following glutathione exhaustion, requiring prompt IV N-acetylcysteine (NAC) administration; snakebite envenomation requires clinical syndromic differentiation (neurotoxic vs cytotoxic vs hemotoxic) and antivenom administration, avoiding traditional tourniquets and local incisions.

Last updated: September 2026

4.3 Neurological Emergencies & Acute Toxicology

Core Clinical Rule: In suspected Acute Bacterial Meningitis , never delay antibiotic administration for a CT scan or lumbar puncture if the patient is unstable or imaging will take > 30 minutes > 30\text{ minutes} > 30 minutes ; obtain blood cultures and administer IV Ceftriaxone 2 g combined with IV Dexamethasone 10 mg immediately. Dexamethasone must be given prior to or concurrently with the first antibiotic dose; administering it hours after antibiotics confers no benefit. In Status Epilepticus , time is brain: after 5 minutes of continuous convulsion, neuronal death accelerates; escalate without delay through the emergency pharmacological protocol.

Neurological emergencies and acute poisonings represent some of the most critical, time-sensitive presentations encountered by Clinical Officers in casualty departments across Kenya. Rapid identification of meningeal inflammation, distinguishing stroke subtypes, arresting prolonged seizures, and delivering antidotal therapy in pesticide or venom toxicity can mean the difference between complete neurological recovery and fatal multiorgan failure.

1. Acute Bacterial Meningitis

Acute Bacterial Meningitis is a life-threatening infection of the arachnoid mater, pia mater, and intervening cerebrospinal fluid (CSF). Pathogens reach the subarachnoid space via hematogenous dissemination from nasopharyngeal colonization or direct contiguous spread (otitis media, mastoiditis, sinusitis, or penetrating skull trauma).

Microbial Etiology by Patient Age & Predisposition

Neonates ( < 1 month < 1\text{ month} < 1 month ): Streptococcus agalactiae (Group B Streptococcus), Escherichia coli , and Listeria monocytogenes .

Infants, Children & Adults ( 1 month − 50 years 1\text{ month} - 50\text{ years} 1 month − 50 years ): Streptococcus pneumoniae (Pneumococcus; leading cause across all ages in Kenya), Neisseria meningitidis (Meningococcus; epidemic potential in the African meningitis belt), and Haemophilus influenzae type b (unimmunized individuals).

Older Adults ( > 50 years > 50\text{ years} > 50 years ) & Immunocompromised: Streptococcus pneumoniae , Neisseria meningitidis , and Listeria monocytogenes (impaired cell-mediated immunity).

Advanced HIV Disease (CD4 < 100 cells / μ L < 100\text{ cells}/\mu\text{L} < 100 cells / μ L ): Cryptococcus neoformans (subacute presentation) and Mycobacterium tuberculosis .

Clinical Presentation & Physical Examination

The Classic Clinical Triad: Fever , nuchal rigidity (neck stiffness) , and altered mental state (present in > 70 % > 70\% > 70% of adults; virtually all patients exhibit at least two signs from fever, headache, neck stiffness, and altered consciousness).

Meningeal Irritation Signs:

Kernig's Sign: With the patient supine and hip flexed at 90°, passive extension of the knee elicits severe resistance and pain in the posterior thigh.

Brudzinski's Sign: With the patient supine, passive flexion of the neck induces involuntary spontaneous flexion of the hips and knees.

Jolt Accentuation: Worsening of headache by rotating the head horizontally at a frequency of 2 to 3 rotations per second (highly sensitive physical sign).

Signs of Raised Intracranial Pressure (ICP): Depressed Glasgow Coma Scale (GCS), papilledema, cranial nerve palsies (CN III and VI), and Cushing's Triad ( bradycardia , systolic hypertension with widened pulse pressure , and irregular/agonal respirations ; heralds impending brainstem herniation).

Lumbar Puncture (LP) & CSF Analysis

Contraindications to Immediate LP (Mandating CT Prior to Puncture): New-onset focal neurological deficits, new-onset seizures within 1 week, papilledema, severely depressed consciousness ( G C S < 10 GCS < 10 GCS < 10 ), or known immunocompromise. If a head CT is required, draw blood cultures and immediately administer IV Ceftriaxone + Dexamethasone before transporting the patient to the scanner!

Cerebrospinal Fluid Parameter Normal Reference Acute Bacterial Meningitis Acute Viral (Aseptic) Tuberculous Meningitis Fungal (Cryptococcal)

Opening Pressure 70–180 mmH2O Markedly Elevated ( > 200 − 300 + > 200 - 300+ > 200 − 300 + ) Normal or slightly elevated Elevated ( > 250 mmH 2 O > 250\text{ mmH}_2\text{O} > 250 mmH 2 ​ O ) Markedly Elevated ( > 250 − 400 + > 250 - 400+ > 250 − 400 + )

Visual Appearance Crystal clear Turbid / Purulent / Cloudy Clear Clear or opalescent; fibrin 'cobweb' web Clear to slightly cloudy

White Blood Cell Count < 5 cells/mm 3 < 5\text{ cells/mm}^3 < 5 cells/mm 3 > 1000 − 10 , 000 + cells/mm 3 > 1000 - 10,000+\text{ cells/mm}^3 > 1000 − 10 , 000 + cells/mm 3 10 − 500 cells/mm 3 10 - 500\text{ cells/mm}^3 10 − 500 cells/mm 3 100 − 500 cells/mm 3 100 - 500\text{ cells/mm}^3 100 − 500 cells/mm 3 20 − 500 cells/mm 3 20 - 500\text{ cells/mm}^3 20 − 500 cells/mm 3

Predominant Cell Type Mononuclear (lymphocytes) Neutrophils ( ≥ 80 % \ge 80\% ≥ 80% ) Lymphocytes (early PMNs) Lymphocytes Lymphocytes

Protein Level 0.15–0.45 g/L Markedly Elevated ( > 1.0 − 5.0 + g/L > 1.0 - 5.0+\text{ g/L} > 1.0 − 5.0 + g/L ) Normal to slightly high ( < 1.0 < 1.0 < 1.0 ) Markedly Elevated ( 1.0 − 5.0 + g/L 1.0 - 5.0+\text{ g/L} 1.0 − 5.0 + g/L ) Elevated ( 0.5 − 2.0 g/L 0.5 - 2.0\text{ g/L} 0.5 − 2.0 g/L )

Glucose (CSF : Serum Ratio) ≥ 0.60 \ge 0.60 ≥ 0.60 ( > 60 % > 60\% > 60% ) Markedly Low ( < 0.40 < 0.40 < 0.40 or < 2.2 mmol/L < 2.2\text{ mmol/L} < 2.2 mmol/L ) Normal ( > 0.60 > 0.60 > 0.60 ) Very Low ( < 0.30 < 0.30 < 0.30 ) Low to normal ( < 0.40 − 0.50 < 0.40 - 0.50 < 0.40 − 0.50 )

Diagnostic Microbiology Sterile Gram stain positive 60–80%; culture PCR positive (Enterovirus, HSV) AFB positive (GeneXpert MTB/RIF) India Ink positive (yeast capsules) ; CrAg LFA

Stepwise Pharmacological Management Protocol

Empirical Antibiotic Therapy:

Adults ( 1 month − 50 years 1\text{ month} - 50\text{ years} 1 month − 50 years ): IV Ceftriaxone 2 g every 12 hours (or IV Cefotaxime 2 g every 6 hours) infused over 30 minutes for 10 to 14 days.

Neonates, Adults > 50 years > 50\text{ years} > 50 years , or Immunocompromised: Add IV Ampicillin 2 g every 4 hours to cover Listeria monocytogenes (resistant to all cephalosporins).

Adjunctive Corticosteroid Therapy (Dexamethasone):

Dose & Administration: IV Dexamethasone 10 mg administered 15 to 20 minutes before or concurrently with the first antibiotic dose , continued at 10 mg IV every 6 hours for 4 days .

Evidence-Based Rationale: Antibiotic-induced bacterial lysis releases cell wall endotoxins and teichoic acid fragments, triggering intense subarachnoid inflammation. Dexamethasone blunts cytokine release (TNF-alpha, IL-1), significantly reducing sensorineural hearing loss, neurological sequelae, and overall mortality in pneumococcal meningitis.

Chemoprophylaxis for Close Contacts (Meningococcal Disease):

Single dose Oral Ciprofloxacin 500 mg , OR Oral Rifampicin 600 mg twice daily for 2 days , OR single dose IM Ceftriaxone 250 mg (preferred in pregnant women).

2. Acute Stroke Management

Stroke is an acute focal neurological deficit of vascular origin lasting > 24 hours > 24\text{ hours} > 24 hours or leading to death. Approximately 85% are Ischemic Strokes (thrombotic, cardioembolic secondary to atrial fibrillation, or lacunar) and 15% are Hemorrhagic Strokes (intracerebral hemorrhage [ICH] secondary to chronic hypertension or Charcot-Bouchard microaneurysm rupture, or subarachnoid hemorrhage [SAH] secondary to saccular 'berry' aneurysm rupture).

The FAST Assessment Protocol

F - Face: Sudden facial droop, asymmetry when smiling.

A - Arms: Arm drift or motor weakness when held elevated at 90° for 10 seconds.

S - Speech: Slurred speech, expressive aphasia, or inability to repeat simple phrases.

T - Time: Document the precise 'last known normal' time and transport urgently.

Emergency Neuroimaging: The First Crucial Step

Every suspected stroke patient requires an immediate Non-Contrast Brain CT (NCCT) . It is clinically impossible to distinguish ischemic from hemorrhagic stroke without imaging. NCCT reveals:

Hemorrhagic Stroke: Immediate hyperdense (bright white) intraparenchymal blood or blood within the basal cisterns.

Ischemic Stroke: Typically normal in the initial hyperacute window ( < 3 − 6 hours < 3 - 6\text{ hours} < 3 − 6 hours ), or shows subtle early ischemic changes (loss of insular ribbon, sulcal effacement, dense middle cerebral artery [MCA] sign). Its primary emergency role is to definitively rule out intracranial hemorrhage .

Acute Blood Pressure Management Strategy +-----------------------------------------------------------------------------------+

  • | BLOOD PRESSURE TARGETS IN ACUTE STROKE |
  • +-----------------------------------------------------------------------------------+
  • | ISCHEMIC STROKE (NOT Eligible for Thrombolysis / Conservative): |
  • | • PERMISSIVE HYPERTENSION: Withhold antihypertensives unless: |
  • | Systolic BP > 220 mmHg OR Diastolic BP > 120 mmHg. |
  • | • Rationale: Cerebral autoregulation is lost in the ischemic penumbra. Blood flow |
  • | is linearly dependent on systemic MAP. Lowering BP precipitates penumbral death! |
  • | • If BP > 220/120: Cautiously reduce MAP by 15% over the first 24 hours using IV |
  • | Labetalol (10-20 mg IV) or Nicardipine. |
  • +-----------------------------------------------------------------------------------+
  • | ISCHEMIC STROKE (Eligible for Intravenous Thrombolysis with Alteplase): |
  • | • Pre-treatment BP must be strictly reduced to < 185/110 mmHg. |
  • | • Post-thrombolysis BP must be maintained < 180/105 mmHg to prevent hemorrhage. |
  • +-----------------------------------------------------------------------------------+
  • | ACUTE INTRACEREBRAL HEMORRHAGE (Hemorrhagic Stroke): |
  • | • Rapid, controlled lowering of Systolic BP to target 140 mmHg (range 130-150) |
  • | within 1-2 hours using IV Labetalol or Hydralazine to limit hematoma expansion. |
  • +-----------------------------------------------------------------------------------+
  • Antiplatelet & Supportive Protocols

Aspirin Loading: In acute ischemic stroke, administer chewable Aspirin 300 mg orally or rectally within 24 to 48 hours after symptom onset, provided intracranial hemorrhage is excluded on CT. If intravenous thrombolysis was administered, hold aspirin for 24 hours post-thrombolysis.

Glycemic Control: Maintain blood glucose between 7.8 and 10.0 mmol/L; treat hyperglycemia ( > 10.0 mmol/L > 10.0\text{ mmol/L} > 10.0 mmol/L ) with subcutaneous soluble insulin. Avoid hypotonic intravenous dextrose solutions (causes cerebral edema).

Temperature Control: Aggressively treat pyrexia ( > 37.5 ∘ C > 37.5^\circ\text{C} > 37. 5 ∘ C ) with paracetamol; fever increases metabolic rate and accelerates penumbral necrosis.

  • 3. Status Epilepticus Stepwise Emergency Protocol
  • Operational Definition

Status Epilepticus is defined as a continuous, unremitting seizure lasting ≥ 5 minutes \ge 5\text{ minutes} ≥ 5 minutes , or two or more discrete seizures without complete interictal recovery of consciousness . The traditional 30-minute definition has been abandoned because irreversible excitotoxic neuronal injury (NMDA receptor activation and intracellular calcium influx) and pharmacoresistance begin at 5 minutes.

  • Timed Stepwise Pharmacological Algorithm [0 to 5 MINUTES: INITIAL STABILIZATION]
  • Airway: Position in lateral recovery position, suction secretions, insert nasopharyngeal airway
  • Breathing: 100% High-flow oxygen via non-rebreather mask; monitor SpO2
  • Circulation: Establish IV access, draw blood for glucose, electrolytes, FBC, anticonvulsant levels
  • Check Point-of-Care Blood Glucose: If < 3.5 mmol/L, give 50 mL of 50% Dextrose IV (+ Thiamine 100 mg IV)
  • |
  • v (Seizure continues >= 5 minutes)
  • [5 to 10 MINUTES: FIRST-LINE THERAPY - EMERGENT PHASE]
  • IV Diazepam: 10 mg slow IV push (2-5 mg/min). May repeat ONCE at 10 minutes if seizures persist
  • (Alternatives: IV Lorazepam 4 mg, or Rectal Diazepam 10-20 mg, or IM Midazolam 10 mg)
  • |
  • v (Seizure continues >= 10-15 minutes)
  • [10 to 30 MINUTES: SECOND-LINE THERAPY - URGENT CONTROL PHASE]
  • IV Phenytoin Loading Dose: 18 to 20 mg/kg IV infused in 0.9% Normal Saline at <= 50 mg/min
  • MANDATORY PRECAUTIONS: Continuous ECG and blood pressure monitoring (risk of severe hypotension

and ventricular arrhythmias). NEVER mix with Dextrose (causes instant chemical precipitation).

  • (Alternatives: IV Levetiracetam 60 mg/kg over 10 min, or IV Sodium Valproate 40 mg/kg over 10 min)
  • |
  • v (Seizure continues >= 30 minutes)
  • [> 30 MINUTES: THIRD-LINE THERAPY - REFRACTORY STATUS EPILEPTICUS]
  • Emergent Endotracheal Intubation & Mechanical Ventilation in HDU / ICU
  • Continuous General Anesthetic Infusion titrated to EEG burst suppression:
  • Propofol: 1-2 mg/kg IV bolus, then continuous infusion at 2-10 mg/kg/hour, OR
  • Midazolam: 0.2 mg/kg IV bolus, then continuous infusion at 0.05-2.0 mg/kg/hour
  • 4. Acute Toxicology in the Kenyan Setting
  • Organophosphate & Carbamate Poisoning

Organophosphates (e.g., diazinon, malathion, chlorpyrifos) and carbamates are common agricultural pesticides in Kenya. They bind to and inhibit the enzyme acetylcholinesterase (AChE) through phosphorylation, leading to massive accumulation of acetylcholine at muscarinic, nicotinic, and central nervous system synapses. +-----------------------------------------------------------------------------------+

  • | ORGANOPHOSPHATE TOXIDROME: CLINICAL MANIFESTATIONS |
  • +-----------------------------------------------------------------------------------+
  • | MUSCARINIC OVERDRIVE: "SLUDGE" / "DUMBELS" |
  • | • Salivation (copious pooling) • Diarrhea |
  • | • Lacrimation (tearing) • Urination |
  • | • Urination • Miosis (pinpoint, unreactive pupils) |
  • | • Defecation • Bradycardia |
  • | • GI distress (cramping, vomiting) • Bronchorrhea (masses of watery secretions)|
  • | • Emesis • Bronchospasm (severe wheeze / stridor) |
  • | • Emesis |
  • | • Lacrimation / Salivation |
  • | *PRIMARY KILLER: Asphyxiation from copious Bronchorrhea & Bronchospasm ('wet chest')|
  • +-----------------------------------------------------------------------------------+
  • | NICOTINIC OVERDRIVE: |
  • | • Striated muscle fasciculations, muscle twitches, profound muscular weakness, |
  • | and diaphragmatic respiratory muscle paralysis. |
  • +-----------------------------------------------------------------------------------+
  • | CENTRAL NERVOUS SYSTEM OVERDRIVE: |
  • | • Anxiety, restlessness, confusion, generalized seizures, central coma. |
  • +-----------------------------------------------------------------------------------+

Stepwise Resuscitation Protocol:

Personal Protective Equipment (PPE): Healthcare personnel must wear nitrile gloves and fluid-impermeable aprons to prevent transdermal poisoning.

Decontamination: Immediately strip off all contaminated clothing and store in sealed plastic bags. Wash the patient's entire skin, hair, and nails thoroughly with copious soap and water.

Airway & Oxygenation: Suction airway aggressively; administer high-flow oxygen. Hypoxemic patients have high risk of ventricular fibrillation if atropine is given without oxygenation.

Intravenous Atropine (Competitive Muscarinic Antagonist):

Administer Atropine 2 to 5 mg IV bolus immediately.

Double the dose every 5 to 10 minutes if there is no response (e.g., 2 mg → \rightarrow → 4 mg → \rightarrow → 8 mg → \rightarrow → 16 mg), until complete atropinization is achieved.

CLINICAL ENDPOINTS OF ATROPINIZATION: Clear lungs on auscultation (complete resolution of bronchorrhea and bronchospasm) , heart rate > 80 bpm > 80\text{ bpm} > 80 bpm , systolic BP > 90 mmHg > 90\text{ mmHg} > 90 mmHg , and dry axillae/skin. Critical Rule: Pupillary dilation (mydriasis) alone is NOT an endpoint of atropinization! Tachycardia and mydriasis can be driven by nicotinic receptors; never stop atropine if the lungs remain 'wet' with secretions.

Maintain continuous atropine infusion (10–20% of the total dose required for initial atropinization per hour) for 24 to 48 hours.

Pralidoxime (2-PAM) (Oxime Cholinesterase Reactivator):

Administer Pralidoxime 1 to 2 g IV in 100 mL saline over 30 minutes , followed by an infusion of 500 mg/hr. Oximes detach the organophosphate moiety from AChE before irreversible covalent 'aging' occurs, reversing nicotinic skeletal muscle weakness and fasciculations .

Acute Paracetamol (Acetaminophen) Poisoning

Pathophysiology: At therapeutic doses, 90% of paracetamol undergoes hepatic glucuronidation and sulfation. Approximately 5–10% is metabolized by cytochrome P450 (CYP2E1) into the highly reactive, electrophilic toxic metabolite N-acetyl-p-benzoquinone imine (NAPQI) , which is rapidly neutralized by hepatic glutathione to non-toxic mercapturic acid. In acute overdose ( > 150 mg/kg > 150\text{ mg/kg} > 150 mg/kg or > 7.5 − 10 g > 7.5 - 10\text{ g} > 7.5 − 10 g in adults), glucuronidation saturates, CYP2E1 shunts massive amounts to NAPQI, and hepatic glutathione is depleted by > 70 % > 70\% > 70% . Unconjugated NAPQI binds covalently to hepatocyte macromolecules, causing centrilobular hepatic necrosis .

Antidotal Therapy (N-Acetylcysteine - NAC):

NAC acts as a glutathione precursor and glutathione substitute, directly conjugating NAPQI. It is nearly 100% hepatoprotective if initiated within 8 hours of acute ingestion, but remains beneficial even in late-presenting fulminant hepatic failure.

Intravenous NAC Regimen (3-Bag Infusion Protocol):

Bag 1: 150 mg/kg in 200 mL 5% Dextrose infused over 1 hour .

Bag 2: 50 mg/kg in 500 mL 5% Dextrose infused over 4 hours .

Bag 3: 100 mg/kg in 1000 mL 5% Dextrose infused over 16 hours (total dose: 300 mg/kg over 21 hours).

Snakebite Envenomation in Kenya

Envenomation is endemic in arid and semi-arid counties (Baringo, Kitui, Machakos, Kilifi, Turkana). Bites are classified into three primary clinical syndromes based on venom constituents:

Syndrome / Family Characteristic Species Pathophysiological Features Dominant Clinical Manifestations

Cytotoxic / Vasculotoxic Vipers: Puff Adder ( Bitis arietans ), Saw-scaled Viper ( Echis ) Zinc metalloproteinases, phospholipases causing endothelial damage and tissue lysis Severe local swelling , excruciating pain, blistering, extensive tissue necrosis, compartment syndrome

Hemotoxic Colubrids: Boomslang ( Dispholidus typus ), Vine Snake Prothrombin activators causing consumptive coagulopathy (VICC) Systemic bleeding , persistent oozing from bite/venipuncture sites, hematuria, intracranial hemorrhage

Neurotoxic Elapids: Black/Green Mamba ( Dendroaspis ), Cobras ( Naja ) Post-synaptic alpha-neurotoxins or pre-synaptic dendrotoxins blocking neuromuscular transmission Descending flaccid paralysis : bilateral ptosis, external ophthalmoplegia, dysarthria, dysphagia, respiratory arrest

Harmful Traditional Practices to Avoid: Strictly DO NOT make incisions or cuts across the bite site, apply arterial tourniquets (causes ischemia, gangrene, and limb loss), suck venom by mouth, apply potassium permanganate, or apply local snake stones ('black stones').

First-Aid Protocol: Keep patient calm and reassure them; immobilize the bitten limb using a splint and keep it at heart level; remove constricting rings and jewelry; transport urgently to hospital.

Indications for Antivenom (e.g., Inoserp PAN-AFRICA, SAIMR Polyvalent):

Systemic envenomation: Neurotoxicity, systemic bleeding, abnormal 20-Minute Whole Blood Clotting Test (20WBCT) (blood remains liquid in a dry glass tube after 20 minutes), shock, or cardiac arrhythmias.

Severe local envenomation: Swelling involving more than half the bitten limb, rapid progression within hours, or swelling of a whole digit.

Administration: Reconstitute polyvalent antivenom and infuse IV in 200–500 mL 0.9% Normal Saline over 30 to 60 minutes. Keep IV Epinephrine (Adrenaline) 1:1000 at bedside to treat immediate anaphylactoid reactions.